Exact Mass: 363.0997

Exact Mass Matches: 363.0997

Found 51 metabolites which its exact mass value is equals to given mass value 363.0997, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Rufloxacin

7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.0⁵,¹³]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

C17H18FN3O3S (363.1053)

Rufloxacin belongs to the family of Phenylpiperazines. These are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Same as: D02474

8-Hydroxy-5-deazaflavin

7,8-Didemethyl-8-hydroxy-5-deazariboflavin

C16H17N3O7 (363.1066)

7-Methyl-2'-deoxyguanosine-3'-monophosphate

{[5-(6-hydroxy-2-imino-7-methyl-3,7,8,9-tetrahydro-2H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonate

C11H18N5O7P (363.0944)

3-(1,3-Benzodioxol-5-ylmethoxy)-1-chloro-4-(4-fluorophenyl)piperidine

3-[(2H-1,3-benzodioxol-5-yl)methoxy]-1-chloro-4-(4-fluorophenyl)piperidine

C19H19ClFNO3 (363.1037)

4'-(9-Acridinylamino)methanesulfonanilide

N-{4-[(9,10-dihydroacridin-9-ylidene)amino]phenyl}methanesulphonamide

C20H17N3O2S (363.1041)

Candinine

C23H13N3O2 (363.1008)

Factor F0

7,8-Didemethyl-8-hydroxy-5-deazariboflavin

C16H17N3O7 (363.1066)

CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9643; ORIGINAL_PRECURSOR_SCAN_NO 9642 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9675; ORIGINAL_PRECURSOR_SCAN_NO 9673 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9699; ORIGINAL_PRECURSOR_SCAN_NO 9697 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9719; ORIGINAL_PRECURSOR_SCAN_NO 9718 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9686; ORIGINAL_PRECURSOR_SCAN_NO 9684 DATASET 20200303_ENTACT_RP_MIX505; CONFIDENCE standard compound; INTERNAL_ID 357; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9686; ORIGINAL_PRECURSOR_SCAN_NO 9684 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9727; ORIGINAL_PRECURSOR_SCAN_NO 9726

MCULE-5456767090

C17H21N3O2S2 (363.1075)

MCULE-7864100099

C17H21N3O2S2 (363.1075)

Isodiplamine

C20H17N3O2S (363.1041)

(-)-7-bromohomotrypargine

C16H22BrN5 (363.1058)

A natural product found in Pseudodistoma opacum.

Asp Asp Asp

C12H17N3O10 (363.0914)

Rufloxacin

C17H18FN3O3S (363.1053)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Same as: D02474

Thiazolidine, 3-[(4-ethoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C18H21NO3S2 (363.0963)

LOXITANE C

Loxapine hydrochloride

C18H19Cl2N3O (363.0905)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

n-{2-[11-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}ethanimidic acid

C20H17N3O2S (363.1041)

2-{12-oxoindolo[2,1-b]quinazolin-6-ylidene}-1h-indol-3-one

C23H13N3O2 (363.1008)

n-(2-{6-oxa-4-thia-9,19-diazapentacyclo[10.7.1.0³,⁷.0⁸,²⁰.0¹³,¹⁸]icosa-1,3(7),8,10,12(20),13,15,17-octaen-2-yl}ethyl)ethanimidic acid

C20H17N3O2S (363.1041)

n-{2-[16-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}ethanimidic acid

C20H17N3O2S (363.1041)